
Rutopiper 4000mg/500mg Injection
Marketer
Anevay Pharmaceuticals Pvt. Ltd.
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Rutopiper 4000mg/500mg Injection
Combiflox 4000mg/500mg Injection is a dual-antibiotic formulation indicated for treating diverse bacterial infections. Its mechanism involves microbial eradication. Administration should be solely by a medical professional; self-injection is strictly prohibited. Dosage and frequency are determined by your physician based on your condition's severity, adhering strictly to their prescribed regimen. Commonly reported adverse effects encompass nausea, emesis, diarrhea, and skin rashes. Injection site reactions such as localized pain, edema, or erythema are also possible. Persistent or worsening side effects necessitate immediate medical consultation. Prior to commencing treatment, inform your doctor of any antibiotic allergies, hepatic, or renal impairments. Dosage adjustments or alternative therapies may be warranted. Under medical guidance, this medication is generally considered safe for pregnant and lactating individuals.
Uses of Rutopiper 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Rutopiper 4000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Rutopiper 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Rutopiper 4000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Rutopiper 4000mg/500mg Injection works:
Rutopiper 4000mg/500mg injection contains piperacillin, an antibiotic, and tazobactam, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactam's role is to counteract bacterial resistance mechanisms, thus boosting piperacillin's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
Rutopiper 4000mg/500mg Injection's concurrent use with alcohol presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Rutopiper, 4000mg/500mg, is typically deemed safe for use in pregnant individuals. Preclinical trials in animals revealed minimal or absent harm to offspring; nevertheless, clinical data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Rutopiper 4000mg/500mg Injection is considered safe for breastfeeding mothers. Research in humans indicates negligible transfer of the medication into breast milk, posing no apparent risk to the infant.
DrivingCONSULT YOUR DOCTOR
Rutopiper 4000mg/500mg Injection's effect on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with impaired kidney function should receive Rutopiper 4000mg/500mg Injection with close monitoring. Dosage modification may be necessary for such patients. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Rutopiper 4000mg/500mg Injection in patients with liver impairment appears to present a low risk. Current evidence indicates dose modification for this medication may be unnecessary in such individuals; however, medical advice is recommended.
What if you forget to take Rutopiper 4000mg/500mg Injection :
Omit a Rutopiper 4000mg/500mg Injection dose? Seek medical advice immediately.
Facts to Know About Rutopiper 4000mg/500mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Classification | Drugs combating infection |
